Neurocrine Biosciences Issues Tardive Dyskinesia Consensus
Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the presentation of the first expert consensus recommendations focused on screening,...
Scott Machut Joins Alliant for Value-Based Healthcare Solutions
Machut has 30 years of experience in insurance, reinsurance, and management consulting Scott Machut has...
Galaxy Brain Scientific Advances Personalized Parkinson’s Treatment
A research team led by Prof. Hesheng Liu, founder and Chief Scientific Officer of Galaxy Brain Scientific...
OneMedNet & Navidence Collaborate on Pharma Real-World Data
OneMedNet Corporation (Nasdaq: ONMD) (the “OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provider...
BOOST Pharma Appoints Leading Biopharma Leader Elaine Jones as Chair
Seasoned life science investor, executive and board leader to support next phase of growth as...
Convergent Therapeutics Appoints Michael Rossi to its Board of Directors
Rossi Brings Decades of Leadership as Convergent Advances its Alpha-based Radioantibody for Prostate Cancer to...
